# CRISPR Therapeutics AG: Form 8-K, filed Feb 11, 2025

- Company: [CRISPR Therapeutics AG](/companies/crsp.md) (CIK 1674416)
- Form: 8-K
- Filed: 2025-02-11
- Accepted by EDGAR: Feb 11, 2025, 16:05 ET
- Period: 2025-02-11
- Accession: 0000950170-25-017879
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674416/000095017025017879/crsp-20250211.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674416/000095017025017879/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674416/000095017025017879/crsp-20250211.htm

Filed Feb 11, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-017879. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.